documents: FDA-2023-N-4973-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2023-N-4973-0001 FDA FDA-2023-N-4973 Bayer HealthCare Pharmaceuticals Inc., et al.; Withdrawal of Approval of CIPRO (Ciprofloxacin Hydrochloride) Oral Tablet, Equivalent to 100 Milligrams Base, and Five Generic Ciprofloxacin Hydrochloride, Oral Notice Withdrawal 2023-12-08T05:00:00Z 2023 12 2023-12-08T05:00:00Z   2023-12-08T15:17:20Z 2023-27015 0 0 09000064863166f5

Links from other tables